chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report as received from a physician refers to unknown number of patients. The patient was vaccinated with 2 doses of M-M-R II (lot number, route, dose and injection site were not reported) on an unknown date for recommended immunization schedule. No other co-suspects were reported. No concomitant medications were reported. On an unknown date the patients were vaccinated with 2 doses of M-M-R II as children had no titers at the time of report. The outcome was unknown at the time of report. It was unspecified if the patient had sought medical attention. Additional information is not expected.
Moderna 1/29/21, 3/5/21, 10/29/21. Positive on 7/25/22
p/vax pt was 1mo preg @ time of vax;pt sought unspecified medical treatment;f/u from MD indicated that pt went to hosp couldn't get heartbeat;pt lost the baby & a dilation & currettage was performed;60 day follow-up dated 10/25/00 provided no additional data.
Redness to injection site 2x2 to inj. (L) arm site. Bruise lump, itching.
Developed chest pain that subsided within a few minutes. No other specific signs of a stroke or heart attack. Blood pressure was elevated (~140/85).
Within 2-5 mins after shot, pt c/o tasting medicine-like taste in mouth, tingling sensation that spread from R elbow up R shoulder across head and left neck to left shoulder and lasted less than 1 min. R hand to elbow soreness.
I fainted on my driveway at 05:00 AM the morning after I received the second dose of the Pfizer covid vaccine during my drill weekend for the  and I was rushed to the ER by my father. The Doctor told me that I was severely dehydrated, had low blood pressure, and low blood sugar.
16 hours after injection, Heart Attack, 100% blockage of LAD. Outcome was stent placement, extent of heart damage tbd. Overnight Hospitalization, IV fluids, Blood thinners, Beta Blockers started Historically, with the first 3 shots, little to no sleep for 1 night, heart rate at 10-15 BPM higher consistently for the first day even at rest. General malaise for 1 day, followed by no further symptoms.
Fever 102.5 degrees, severe headache, severe muscle pain, redness and swelling at the site of injection (10x20 cm area on the left upper arm, where pneumonia and flu shot - seasonal+H1N1 were given), extreme fatigue, dizziness. Symptoms continued for 72 hrs. Tylenol, ibuprofen, antihistamine were used, but they could not control fever for 48 hrs.
Patient returned to the pharmacy 4 days later with complaints of rash, arm soreness, itchiness, and swelling.
experienced a headache after the 1st shot; This is a spontaneous report from a Pfizer sponsored program. A contactable consumer (patient's husband) reported for a Female patient (wife). A patient on an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. The patient medical history and medications were not reported.  On an unspecified date, the patient experienced a headache after the first shot. The reporter inquired whether the patient can take Tylenol or Advil. The outcome of event was unknown.  Information on Lot/Batch has been requested.  Follow-up (16Apr2021): This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made.
Patient stated that immediately/within 5 minutes of the vaccine being given, it became difficult to swallow. Patient stated she could walk/was not dizzy or nauseous, no trouble breathing, but would like to go to a private room for observation and wanted to walk there herself. Once inside private room, vitals taken. HR 62, O2Sat 99%, BP 155/100. Patient speaking without difficulty. Patient stated she was having difficulty breathing and her brow began to perspire.  ED offered. Patient accepted. ED nurse came to take her to the ED.
The pt experienced an orange sized red spot to the right thigh area. The area was very warm to the touch with a hard place underneath. Was to take the child to the MD, but the area was gone on  3/9/00, so they did not go to the MD.
HCP reporting she administered GARDASIL 9 to a patient that was 12 days expired.; No additional AE.; This spontaneous report was received from a nurse and refers to a currently 40-year-old male patient. There was no information about the patient's concomitant therapies, drug reactions, allergies or medical history provided  On an unknown date, the patient was vaccinated with 12 days expired hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) as prophylaxis (dose, dose number, lot #, expiry date, route of administration and anatomical location were not provided) (expired vaccine used). The nurse was inquiring if the dose was valid or needed repeated and was informed that without an expiration date and date of administration, information regarding the validity of the product could not be provided. No additional adverse event (AE) was reported.
No adverse event; Vaccine administered beyond expiry date; This spontaneous case was reported by a non-health professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine administered beyond expiry date) and NO ADVERSE EVENT (No adverse event) in an 18-month-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. AS1414B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 12-Jul-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine administered beyond expiry date). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine administered beyond expiry date) and NO ADVERSE EVENT (No adverse event) outcome was unknown.            Concomitant medication was not provided. Treatment medication information was not provided by the reporter. Vaccine received on 07-Jun-2022. Vaccine BUD date reported as 07-Jul-2022.
Felt like skull was crushing my brain. Hips hurt. Fever. Chills. Weak.
Patient sought medical evaluation on 29 August for a pruritic, papular rash that began on post-vaccine day 15 (8/24/16). Rash began on upper extremities, then noted on lower extremities and neck and face. No rash on trunk. Patient's smallpox vaccination site progressed as expected without significant local reaction. (However, on post-vaccine day 9, patient sought evaluation of left supraclavicular lymph node that was swollen and tender.) Patient denies fever, chills, body aches, chest pain, shortness of breath, headaches, and malaise. He also denied any other potential triggering headaches and malaise. He also denied any other potential triggering exposures, other than travel. No prior history of skin conditions. PMH reported as negative. Patient evaluation included differential diagnoses of nonviral pustulosis, benign acral papulovesicular eruptions, generalized vaccinia, contact dermatitis and heat rash. Patient was treated with antihistamine and instructed on actions to avoid potential contact transmission as a precaution. Also, patient exposure to sun and skin irritation were limited. Patient evaluated on 1 Sep 2016 - Lesions on face consistent with acne. Lesions on arms, neck and ankle are dry.
Child developed 2" rash area around DTaP inject site - some rash on stomach also noted.
Patient completed COVID vaccine observation period with no issues.  Then left observation area but returned a short time later  complaints of rash on left shoulder/side.   Pt took diphenhydramine 50mg by mouth prior to returning to observation area.  Observed for an additional 30 minutes, pt declined  ED evaluation and departed.
Covid 19; I tested positive for Covid 19 on August 12, 2022 I experienced headaches; body aches; sneezing; fever; coughing; congestion; runny nose. I took PAXLOVID for my symptoms.
Individual was given 0.3ml of undiluted pfizer-Biotech.  Patient was observed and had no abnormal signs or symptoms of adverse event two hours post vaccination administration. Vitals with in normal limits for patient.
Approximately 26 hours after second vaccine I began to feel fatigued, achy, congestion, cough, sneezing and overall malaise. This continued to present (3.28.21) however the congestion is much improved and no more cough.
Severe pain in arm with PNEUMOVAX-23 injection pt. said it was so painful that she couldn't lift up her arm.
Sore need of whole right side of the body, including arm and leg where shot was given. Lethargy and paleness followed around 1pm and fever came on by 3pm. Fever was not brought down by Advil and 3 hours after first dose of Advil fever was still 102. Child was restless that night and fever continues for 3 days. Also lack of appetite and diarrhea throughout the 3 days.
Patient presented to office for MENACTRA and ADACEL. Vaccines given pt very anxious Perma. Pt rested in room for 10 min prior to standing. Proceeded to check out and became light headed and passed out at approx 15:50 PM. She was in our office for a total of 40 min post vaccine.
Sre shoulder that got worse every day, significant pain on third day, acute shoulder tendonitis, impingement diagnosed Nov 16 2015.  Extreme pain and lack of mobility.
This spontaneous report was received from Registered Nurse who reported that on unspecified dates a unknown number of patients (ages and genders not reported) were vaccinated a dose of with (Oka/Merck) VARIVAX which were improperly stored. No adverse effects were reported. This report is linked to MARRS1410USA004588, 1410USA009956, 1410USA009957, 1410USA00958, 1410USA009959 and 1410USA009960. Additional information has been requested.
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On an unknown date, in 2014 (reported as "last year"), the patient was vaccinated with the first dose of ZOSTAVAX (dose, route of administration, lot # and expiration date were not reported). On 21-OCT-2015, the patient was vaccinated with the second dose of ZOSTAVAX lot # L028281, expiration date 28-OCT-2016 (dose and route of administration were not reported). There was no adverse effect reported. Additional information has been requested.
Approximately 4 hours after vaccination had onset fever, chills, diarrhea, palpitations, tingling left arm and lethargy. 31 hours later (current 458 PM) symptoms continue.
This spontaneous report was received from a licensed practical nurse concerning an unspecified patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On an unknown date, the unspecified patient was vaccinated with an improperly stored dose of PROQUAD injection, by subcutaneous route, lot number M042497, expiration date: 17-APR-2018 (strength and dose were not reported) for prophylaxis. The temperature excursion with PROQUAD was in the range of 6 to 14 Fahrenheit degrees for 7 hours and 51 minutes. No previous temperature of excursion was performed. The temperature excursion was detected by a data logger. No adverse effects were reported. Additional information has been requested.
Nurse calling to report VARIVAX was administered to patient while it had a temperature excursion. Exact date of administration not provided. Patient is asymptomatic. No additional AE. No PQC. Names of vaccines involved (including lot/exp) VARIVAX W03; No Adverse Event; This spontaneous report as received from a nurse refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported.  On an unknown date, the patient was vaccinated with one dose of improper storage varicella virus vaccine live (oka/merck)(VARIVAX) lot #W031812, expiration date: 05-OCT-2024, (exact dose, route of administration and anatomical location were not reported) for prophylaxis.  Administered dose of vaccine experienced the temperature excursion of 24.4 degrees Fahrenheit for 5 hours and 51 minutes (product storage error). No previous temperature excursion had occurred. There were no additional adverse events reported (no adverse event).
Pfizer BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 1/28/2021 and 2/23/2021. He began to feel unwell on 9/12 and tested COVID+ on 9/14. He began to have progressive dyspnea and fevers at home up to 103 F so he presented on 9/19 to ED. SpO2 was in 70s on RA, failed NRB, and was placed on HFNC. CTA chest negative for PE but notable for extensive GGO and alveolar infiltrates. He was also found to have an AKI and elevated LFTs. He was admitted to HCF due to HCF requirements. He was started on Decadron. Dr was consulted who recommended Remdesivir and okay with continuation of his cellcept. He was determined not to be a candidate for Toci or Baricit a. He was started on empiric abx. Unfortunately, he decompensated requiring intubation. Despite supportive measures, he slowly clinically declined with multisystem organ failure including ARF requiring dialysis. He was compassionately extubated and passed at 1225 10/1/21.
Up to date on all vaccines, got shingles/suspected vaccination failure; I was in recovery of shingles broke out; Was in recovery of covid; In addition to the already blisters; Scratched so hard my skin bled; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a 75-year-old patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: Up to date on all vaccines, got shingles/suspected vaccination failure) (serious criteria GSK medically significant), shingles (Verbatim: I was in recovery of shingles broke out), covid-19 (Verbatim: Was in recovery of covid), blister (Verbatim: In addition to the already blisters) and scratch (Verbatim: Scratched so hard my skin bled). The patient was treated with topical steroid nos (Steroid Cream). The outcome of the vaccination failure was unknown and the outcome of the shingles and covid-19 were recovering/resolving and the outcome of the blister and scratch were not reported.   It was unknown if the reporter considered the vaccination failure, shingles, covid-19, blister and scratch to be related to Shingles vaccine.     It was unknown if the company considered the vaccination failure, shingles, covid-19, blister and scratch to be related to Shingles vaccine.   Additional Information: GSK receipt date: 2-Mar-2023 The case was received from the patient via interactive digital media. The patient stated that same with him/her. The patient was in recovery of covid and shingles broke out.  The patient scratched so hard his/her skin bled in addition to the already blisters and 2 different rounds of steroid topical cream.  The patient stated that yes, he/she was up to date on all vaccines. The patient was never thought this dreadful shingles would get him/her.  No one was immune. This case was considered as suspected vaccination failure since the details regarding the completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were unknown at the time of reporting. The follow-up could not be possible as no contact details were available.
This spontaneous report was received from a registered nurse refers to unspecified number of patients of unknown age and gender. No medical history or concomitant medication were reported. On an unknown date the patients were vaccinated with improperly stored doses of M-M-R II (lot number-J002504, expiry date-25-FEB-2015, dosing regimen unknown) following multiple excursions, that started on an unspecified date in February 2014 and have persisted until an unspecified date during the last month. It was reported that the excursions were recently discovered during a Vaccines for Children audit and that no specified dates of administration was currently available. No doses were administered after their expiration dates. PNEUMOVAX 23 and M-M-R II (K014833, exp: 14-SEP-2016) had appeared on the product list as temperature stability questions were asked about these products, but no doses of these products were administered to any patients. No adverse events were reported. No laboratory tests were reported. No product quality complaint (PQC) was involved.  The outcome of the events was unknown. This is one of several reports received from the same reporter.
This spontaneous prospective pregnancy report as received from a registered nurse refers to a 16 year old female patient. Pertinent medical history and drug allergies were reported as none. On 06-NOV-2013, the patient was vaccinated with GARDASIL (lot # H017698, expiration date 02-JUL-2015, dose 1, 0.5 ml, intramuscular). No concomitant therapy was reported. In 2013 a few weeks later, the patient was confirmed to be pregnant with last menstrual period of 01-OCT-2013 and estimated date of conception of 08-JUL-2014. The patient sought medical attention (office visit). The patient had an ultrasound done at her Obstetrics Gynecology office which confirmed that she was 12 weeks pregnant. The patient did not receive any treatment. The pregnancy outcome was unknown. Additional information has been requested.
Left arm soreness and pain. Began overnight. No skin changes. Painful to touch. Painful with abduction and lifting. Empty Can Test positive.
Very briefly her head slumped backwards. Then she asked what just happened and that she is ok. Pt said she has hx of passing out but that it has not occurred in a long time. Paramedics were called. Her vital signs were ok (BP = 116/66). She refused to go to the hospital.
Patient received Pediatric Pfizer dose as patient needed to receive Pfizer 12+. No adverse reaction accrued.
Patient was taken to Urgent Care Clinic for hives was given BENADRYL and prednisone.
Patient received small pox vaccine 1/25/08; read major re 2/1/08.  Returns 2/5/08 - small pox site - pustale forms scab surrounding erythema, tenderness, warmth, 3" diameter.  Diagnosis - cellulitis 2 small pox vaccination, prescribed Levaquin 750 mg.  2/4 cellulitis resolved.
Following decades of well-controlled hypertension on stable doses of atenolol and lisinopril with consistent blood pressure readings between 110/70 to 120/80, including a physician-visit blood pressure recording of 118/80 on September 29, 2022, a reading at a routine medical appointment, ten days following vaccination, on October 13. 2022, was 162/96.  Daily blood pressure recording remained consistently elevated during October and November 2022, between 132/86 to 146/92, including a physician-documented blood pressure recording of 142/88 on Nov. 7, 2022.  Strict adherence to atenolol and lisinopril without changes in dosing or changes in mediation manufacturer.  Outcome will be enhancement or change in blood pressure medications, to start with increase in lisinopril dosing.  Original COVID vaccine series, and one booster, was with Moderna's mRNA vaccine with stable blood pressure readings in 2021 to October 2022  following vaccinations.
A non-serious spontaneous report of "difficulty swallowing with some throat swelling," headache, spacey feeling, achy and "my eyes hurt" has been received from a 45-year-old physician regarding herself, subsequent to H1N1 2009 MONOVALENT Vaccine. The patient's past medical history and concomitant medications were not reported. The patient received both H1N1 2009 MONOVALENT Vaccine and the flu shot on 27-Oct-2009. Within minutes of vaccination, the patient had difficulty swallowing with some throat swelling. Later in the day, she had headache, spacey feeling, achy and "my eyes hurt." The outcome of the adverse events was unknown.
Initial report was received from a company representative on 28 September 2012. An unidentified patient with an unknown past medical history had received ADACEL (lot number, route, site and date of administration not reported) and an unspecified amount of time later, experienced seizures and loss of mobility. No further information was available at the time of the report. The patient's outcome was unknown. Documents held by sender: none.
Headache, Myalgia, Arthralgia, left arm sore, nerve pain Narrative
Doses were given after expiration date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Doses were given after expiration date) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Oct-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Doses were given after expiration date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Doses were given after expiration date) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant products were not provided.  The vial was placed in refrigerator on 21-Sep-2021. It was reported that the expired lots were administered due to the confusion with expiry date printed in the carton and the expiration date when the code was scanned. The vials did not undergo temperature excursion. The patient did not experience any adverse event.  Treatment medications were not reported.
Heart palpitations; Body cramps; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PALPITATIONS (Heart palpitations) and MUSCLE SPASMS (Body cramps) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PALPITATIONS (Heart palpitations) and MUSCLE SPASMS (Body cramps). At the time of the report, PALPITATIONS (Heart palpitations) and MUSCLE SPASMS (Body cramps) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant and treatment medications were provided
54 y/o M presents today for a hospital F/U. He has not seen me for a routine visit since 08/2019. Pt presented to ER on 03/12/2021 with c/o elevated BP and exertional CP. He was noted to have an elevated troponin and transferred to medical center. Pt underwent Exercise stress test which did not show any signs of ischemia. He was discharged on 03/16/2021. Pt has f/u appt with his cardiologist, Dr. on 03/22/2021. Pt notes that he received his first Moderna COVID-19 vaccine dose on 03/11/2021. It was a few hours later that he began to feel the CP. He has no known allergies or contraindications for other vaccines. Per pt, he has not had any CP or pressure since discharge. BP now controlled. Pt admits to occasional palpitations x 1 year, episodes last a few minutes, occur every few days without any associated symptoms. He reports no recent change to these episodes. Last episode occured yesterday, he did not have any palpitations while hospitalized. Pt also admits to headaches since he has not smoked since his hospitalization, using 14mg nicotine patches. Denies f/c, lightheadedness/dizziness, CP, SOB, DOE, abdominal pain, N/V/DC.